MedTrace Logo

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

NCT06566898 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-04-23

No results posted yet for this study

Summary

Monitoring of antimicrobial resistance (AMR) based on metagenomics analyses in pneumonia patients is critical for optimizing clinical diagnosis and treatment and improving clinical prognosis. This study is designed to ask the following key questions:

1. What is the microbiome maps of patients with severe pneumonia and mild pneumonia ?
2. How many pathogen resistance genes are carrying in severe pneumonia and mild pneumonia ?
3. What is the genetic diversity of key pathogens detected in severe pneumonia and mild pneumonia during 2019-2025?

Conditions

Sponsors & Collaborators

  • Wuxi People's Hospital Affiliated to Nanjing Medical University

    collaborator UNKNOWN

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • The Central Hospital of Huanggang

    collaborator OTHER

  • Shanghai General Hospital, China

    lead OTHER

Principal Investigators

  • Mei Kang, MPH · Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-04-15
Completion
2026-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06566898 on ClinicalTrials.gov